Abstract: Example methods and apparatus for providing voice alignment are described. One example method including: obtaining an original voice and a test voice, the test voice is a voice generated after the original voice is transmitted over a communications network; performing loss detection and/or discontinuity detection on the test voice, the loss detection is used to determine whether the test voice has a voice loss compared with the original voice, and the discontinuity detection is used to determine whether the test voice has voice discontinuity compared with the original voice; and aligning the test voice with the original voice based on a result of the loss detection and/or the discontinuity detection, to obtain an aligned original voice and an aligned test voice, the result of the loss detection and/or the discontinuity detection is used to indicate a manner of aligning the test voice with the original voice.

Abstract: Embodiments of the present disclosure relate to a method, a device and a computer program product for managing backup data. The method comprises receiving a first request from a user for managing backup data on a first virtual machine management platform. The method further comprises sending a second request comprising a user identifier and a platform identifier to a backup server. The method further comprises receiving, from the backup server, a first virtual machine identifier of the first virtual machine used by the user on the second virtual machine management platform and backup records corresponding to the first virtual machine identifier. The method further comprises determining, based on the first virtual machine identifier, whether a second virtual machine matched with the first virtual machine is present in the first virtual machine management platform.

Abstract: Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Abstract: Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agents and auris pressure modulators. In these methods, the auris compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the immunomodulating and/or auris pressure modulating compositions and formulations onto the auris media and/or auris interna target areas, or via perfusion into the auris media and/or auris interna structures.

Abstract: Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agents and auris pressure modulators. In these methods, the auris compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the immunomodulating and/or auris pressure modulating compositions and formulations onto the auris media and/or auris interna target areas, or via perfusion into the auris media and/or auris interna structures.

Abstract: A two-part conductive shield for an object or vehicle likely to suffer surface damage includes a first film on an outer surface of the vehicle, and a second film on an inner surface of the vehicle. The films may be applied as coatings. Capacitance of the conductive shield can be measured for reference and for in-use purposes, thus determining whether there is a change in an area of the first film opposite to the second film can indicate a scratch or other surface damage, and an instant warning or prompt given. A scratch detecting apparatus and a scratch detecting method are also provided.

Abstract: A plunge circular saw, including a cutting body and a substrate pivotally connected to the cutting body. The cutting body contains a housing; at least one handle provided on the housing; a motor received within the housing; a circular saw blade mechanically connected to the motor; a battery pack electrically connected to the motor, and a hinge for pivotally connecting the cutting body to the substrate. The battery pack is detachably mounted to a trailing end of the cutting body. The cutting body is pivotable relative to the substrate by the hinge and movable between a cutting position and a parking position. The hinge is disposed at a position between the motor or the circular saw blade and the battery pack. The circular saw provided by the present invention improves the overall parallelism of the circular saw by changing the position of the hinge and gravity distribution thereof, thereby allowing the user to cut the workpiece more easily and accurately.

Abstract: A data analytics device for application monitoring includes an application-monitor manager engine to receive configuration files from a cloud server and to generate monitoring rules for a number of monitors. A data-processing engine is coupled to the application-monitor manager engine and the monitors and coordinates activities of the plurality of monitors. The monitors are embedded in a user space and a kernel of a host operating system, and the monitoring rules for the monitors are generated based on the configuration files.

Abstract: The present disclosure relates to tertiary amine co-initiators that demonstrate reduced leaching and which may be utilized in dental restoration and other biomedical applications. Embodiments of the present disclosure provide compounds and compositions for use in preparing polymers and light curable dental resin composites, as well as methods for preparing photocurable polymer-based dental restorative materials. In one or more disclosed embodiments, a co-initiator for use in preparing a polymer comprises a tertiary amine core and two or more pendant, terminal methacrylate groups. In some embodiments, the co-initiator may also act as a co-monomer in a co-polymerization reaction.

Abstract: Disclosed herein are compositions and methods for the treatment of otic disorders with CNS modulating agent compositions and compositions administered locally to an individual afflicted with an otic disorder, through direct application of these compositions and compositions onto or via perfusion into the targeted auris structure(s).

Abstract: Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agents and auris pressure modulators. In these methods, the auris compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the immunomodulating and/or auris pressure modulating compositions and formulations onto the auris media and/or auris interna target areas, or via perfusion into the auris media and/or auris interna structures.

Abstract: Disclosed herein are compositions and methods for the treatment of otic disorders with anti-apoptotic agent or pro-apoptotic agent compositions and compositions administered locally to an individual afflicted with an otic disorder, through direct application of these compositions and compositions onto or via perfusion into the targeted auris structure(s).

Abstract: Disclosed herein are delivery devices for use in the treatment of otic disorders wherein the delivery device is administered locally to an individual afflicted with an otic disorder, through direct application or via perfusion into the targeted auris structure(s).

Abstract: Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agents and auris pressure modulators. In these methods, the auris compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the immunomodulating and/or auris pressure modulating compositions and formulations onto the auris media and/or auris interna target areas, or via perfusion into the auris media and/or auris interna structures.

Abstract: Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with aural pressure modulating agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Abstract: Disclosed herein are compositions and methods for the treatment of otic disorders with otic structure modulating compositions administered locally to an individual afflicted with an otic disorder, through direct application of these compositions and compositions onto or via perfusion into the targeted auris structure(s).

Abstract: Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Abstract: Disclosed herein are methods for modulation of gel temperature of poloxamer-containing formulations. Also described herein are sustained release pharmaceutical formulations that gel upon contact with the body and are administered by direct application of these compositions and formulations onto or via perfusion into the targeted structure(s).

Abstract: Disclosed herein are compositions and methods for the treatment of otic disorders with steroid, NSAID, and/or adenosine triphosphatase (“ATPase”) modulator agents. In these methods, the steroidal, NSAID, and/or ATPase compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Abstract: The present invention is directed to compositions of bimatoprost, processes of preparing these compositions, devices comprising these compositions, and methods of lowering intraocular pressure.